Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology
Disease Category: Hypogonadism
Trial Information
Role of FSH in Human Gonadal Development
The aim of the research study is to understand the role of FSH, a hormone of the reproductive system, in human gonadal (testis) development and to maximize the fertility potential in the most severely affected men with idiopathic hypogonadotropic hypogonadism (IHH) or Kallmann sydrome (KS).
Eligibility Criteria:
Males diagnosed with IHH or KS and:
1) no history of spontaneous puberty, with small testes (less than or equal to 3 mL)
2) negative MRI of the hypothalamic-pituitary area (a region of the brain)
3) no prior reproductive hormone therapy (gonadotropin injections). Testosterone only is acceptable
Andrew Dwyer, RN, FNP
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Phone: 617-726-8622
EMail: Adwyer@partners.org
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
